Understanding the Nano-Bio Interactions and the Corresponding Biological Responses
Xin Tian1, Yu Chong1, Cuicui Ge1
1State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, China.
Frontiers in Chemistry
|June 27, 2020
Summary
Understanding nanomaterial-biological interactions is key for advancing nanomedicine. This review explores nano-bio interfaces, focusing on corona and redox reactions for safer, effective biomedical applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Materials Science
Background:
- Nanomaterials offer revolutionary potential in biomedicine.
- Understanding nanomaterial-biological microenvironment (nano-bio) interactions is crucial for clinical translation.
- Current knowledge gaps hinder the development of safe and effective nanomedicine.
Purpose of the Study:
- To systematically review nano-bio interfaces and their biological outcomes.
- To highlight the roles of corona and redox reactions in nano-bio interactions.
- To discuss challenges and opportunities in the field of nano-bio interfaces.
Main Methods:
- Literature review of experimental and theoretical developments.
- Focus on corona formation and redox reactions at nano-bio interfaces.
- Analysis of biological outcomes resulting from nano-bio interactions.
Main Results:
- Nano-bio interfaces are critical for understanding nanomaterial behavior in biological systems.
- Corona and redox reactions significantly influence biological responses to nanomaterials.
- Nano-bio interactions provide platforms for diverse biomedical applications.
Conclusions:
- A systematic understanding of nano-bio interactions is essential for designing advanced nanomedicines.
- Further research into nano-bio interfaces will unlock new therapeutic and diagnostic opportunities.
- Addressing challenges in studying these interfaces will accelerate clinical translation.
